Human medicines European public assessment report (EPAR): Celdoxome pegylated liposomal, doxorubicin hydrochloride, Date of authorisation: 15/09/2022, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Celdoxome pegylated liposomal, doxorubicin hydrochloride, Date of authorisation: 15/09/2022, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Entacapone Orion, entacapone, Date of authorisation: 18/08/2011, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Entacapone Orion, entacapone, Date of authorisation: 18/08/2011, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Cegfila (previously Pegfilgrastim Mundipharma), pegfilgrastim, Date of authorisation: 19/12/2019, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Cegfila (previously Pegfilgrastim Mundipharma), pegfilgrastim, Date of authorisation: 19/12/2019, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Aripiprazole Sandoz, aripiprazole, Date of authorisation: 20/08/2015, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Aripiprazole Sandoz, aripiprazole, Date of authorisation: 20/08/2015, Revision: 11, Status: Authorised

Committee for Herbal Medicinal Products (HMPC): 23-25 September 2024, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2024 to 25 September 2024

Committee for Herbal Medicinal Products (HMPC): 23-25 September 2024, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2024 to 25 September 2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.